Omme raises $4.8M seed for men's digital health platform in Mexico
What's the deal? OmmeDealroom has a profile for this one. Try Dealroom →, a Mexico-based digital men's health platform, has raised $4.8 million in a seed round. First Round Capital and Rethink ImpactDealroom has a profile for this one. Try Dealroom → led the round, joined by several healthcare angel investors.
What does Omme do? The company runs an app-based platform combining home testing kits and AI to assess men's health, initially focused on hair loss and erectile dysfunction. Those conditions together affect more than 30 million men in Mexico.
What's the endgame? Omme pairs each patient with a board-certified specialist from day one through prepaid six- and twelve-month programs. It bundles physician-led protocols, AI-powered follow-up, continuous clinical support, and discreet home delivery into a single experience — aiming to build infrastructure for chronic men's healthcare across Latin America.
Why now? Healthcare across the region is shifting from episodic, location-based care toward connected, consumer-led models via telemedicine, online diagnostics, and direct-to-consumer treatment. Omme targets men who, as one backer noted, are "far more likely to search for a health solution online than to walk into a clinic."
The investor thesis: El Poblado Investment GroupDealroom has a profile for this one. Try Dealroom →, which participated, has expanded its healthcare focus within its active Fund III, targeting a fourth-quarter close. "Healthcare is becoming one of the most important areas of opportunity in Latin America," said Mason Mehta, founder and general partner. He said the firm backs companies "redesigning the patient experience around trust, access, privacy, and better outcomes."
The signal: The round sits in the 34.8th percentile by size — a modest seed reflecting the early stage of consumer-led health startups in Latin America. Mexico's population scale, proximity to the US, and rising private-care demand make it a testing ground for models that align business incentives with long-term patient outcomes.
Read more: startupresearcher.com, businesswire.com
Image credit: Generated with Gemini
